2021 annual financial data
Cocrystal Pharma 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was -234.37%.
Operating income was -14,221,000 USD and net income was -14,185,000 USD.
Operating cash flow was -12,719,000 USD.
Get free Cocrystal Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 5,427,000 USD
- Operating income
- -14,221,000 USD
- Net income
- -14,185,000 USD
- Operating cash flow
- -12,719,000 USD